| Application no. and date | 01902375.3 (espacenet) (Federated) (European Patent Register), 20010201 | | Patent/reg. no. and date | DK/EP 1299099, 20051026 | | Publication date | 20030409 | | Priority no. and date | EP 00104531, 20000310 | | EP pub. no. and date |
EP 1299099 20030409 | | Effective date | | | Applicant/owner | Merck Patent GmbH, Frankfurter Strasse 250
64293 Darmstadt, DE | | Applicant ref. no. | P39869DK01 | | Inventor | BARTOSZYK, Gerd, Kreuzstrasse 57
64331 Weiterstadt, DE,
RUSS, Hermann, Zerninstrasse 15b
64297 Darmstadt-Eberstadt, DE,
SEYFRIED, Christoph, Mathildensstrasse 6
64342 Seeheim-Jugenheim, DE,
WEBER, Frank, Meier-Stier-Strasse 10
64846 Gross-Zimmern, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/353 (2006.01) , A61P 25/14 (2006.01) , A61P 25/16 (2006.01) | | Title | Hidtil ukendt anvendelse af (R)-(-)-2-[5-(4-fluorphenyl)-3-pyridylmethyl-aminomethyl]-chroman og fysiologiske acceptable salte heraf | | Int. application no. | EP2001001038 | | Int. publication no. | WO2001068063 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
